Cargando…

Diagnostic evaluation and medication usage in a cohort of subjects with juvenile dermatomyositis from the CARRAnet registry

Detalles Bibliográficos
Autores principales:	Robinson, Angela B, Hoeltzel, Mark F, Reed, Ann M, Huber, Adam, Feldman, Brian M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403047/ http://dx.doi.org/10.1186/1546-0096-10-S1-A64

Ejemplares similares

Clinical characteristics of children with juvenile dermatomyositis recruited within the first 7 months of the CARRAnet registry
por: Hoeltzel, Mark F, et al.
Publicado: (2012)

Race is a risk factor for calcinosis in patients with JDM – early results from the CARRAnet registry study
por: Hoeltzel, Mark F, et al.
Publicado: (2012)

Description of the localized scleroderma subgroup of CARRAnet
por: Wu, Eveline, et al.
Publicado: (2012)

Disease characteristics and medication use in a multicenter cohort of children with juvenile idiopathic arthritis (JIA): preliminary analyses from the CARRAnet registry
por: Ringold, Sarah, et al.
Publicado: (2012)

Use of immunosuppressive medications and prevalence of disability among patients with pediatric systemic lupus erythematosus: initial analysis of the CARRAnet registry
por: Hersh, Aimee, et al.
Publicado: (2012)

Juvenile dermatomyositis in Western Switzerland
por: Enders, F Bellutti, et al.
Publicado: (2011)

Respiratory involvement in juvenile dermatomyositis
por: Fabi, M, et al.
Publicado: (2008)

Thrombotic microangiopathy in juvenile dermatomyositis
por: Frolenko, A, et al.
Publicado: (2011)

Tubuloreticular inclusions in juvenile dermatomyositis: a diagnostically useful marker?
por: Yasin, Shireena A, et al.
Publicado: (2014)

Proposal for the development of an international minimal data collection for juvenile dermatomyositis (JDM)
por: McCann, Liza J, et al.
Publicado: (2011)

Gastroparesis associated with Juvenile Dermatomyositis
por: Martin, N, et al.
Publicado: (2008)

Sleep, fatigue and quality of life in juvenile idiopathic arthritis (JIA) and Juvenile Dermatomyositis (JDM)
por: Avie, Y Butbul, et al.
Publicado: (2008)

Subclinical pulmonary abnormalities in juvenile dermatomyositis
por: Sallum, Adriana M, et al.
Publicado: (2014)

Treatment of refractory juvenile dermatomyositis with tacrolimus
por: Hassan, J, et al.
Publicado: (2008)

Treatment of calcinosis with biphosphonates in juvenile dermatomyositis
por: Bilginer, Y, et al.
Publicado: (2008)

Dyslipidemia in active juvenile dermatomyositis patients
por: Kozu, KT, et al.
Publicado: (2011)

Juvenile dermatomyositis (JDM) sine myositis
por: Schuetz, C, et al.
Publicado: (2011)

The PRINTO provisional definition of remission in juvenile dermatomyositis
por: Lazarevic, D, et al.
Publicado: (2011)

PReS-FINAL-2012: Introducing a new approach to clinical care of juvenile dermatomyositis: the juvenile dermatomyositis multidimensional assessment report
por: Varnier, GC, et al.
Publicado: (2013)

Informatics methodology for the rapid, validated development of clinical research forms in CARRAnet: incorporating user-centered design into the Delphi technique
por: Inman, CJ, et al.
Publicado: (2012)

Evaluation of the cardiovascular system in patients with juvenile dermatomyositis
por: Opoka – Winiarska, Violetta, et al.
Publicado: (2011)

Calcinosis as a complication of juvenile dermatomyositis (JDM)
por: Clara, Malagón, et al.
Publicado: (2011)

The role of etanercept in juvenile dermatomyositis (JDMS) in children
por: Green, Katherine L, et al.
Publicado: (2014)

Change in disease activity after vitamin D supplementation in children with systemic lupus erythematosus and juvenile dermatomyositis
por: Robinson, Angela B, et al.
Publicado: (2012)

8.3 Disease patterns in Danish Juvenile Dermatomyositis patients
por: Mathiesen, PR, et al.
Publicado: (2008)

Juvenile dermatomyositis associated to lymphoepithelioma, a nasopharyngeal carcinoma
por: Bica, BERG, et al.
Publicado: (2011)

Juvenile dermatomyositis: clinical and laboratory charateristics of 18 patients
por: Iglesias, E, et al.
Publicado: (2011)

PReS-FINAL-2131: Hunting for biomarkers in juvenile dermatomyositis
por: Bellutti Enders, F, et al.
Publicado: (2013)

SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile dermatomyositis
por: Enders, Felicitas Bellutti, et al.
Publicado: (2014)

Organ-specific autoantibodies and autoimmune diseases in juvenile systemic lupus erythematosus and juvenile dermatomyositis patients
por: Aikawa, Nadia E, et al.
Publicado: (2012)

Body mass index at diagnosis affects disease course in juvenile dermatomyositis
por: Patwardhan, Anjali, et al.
Publicado: (2012)

What is the mortality of Juvenile Dermatomyositis (JDM) in the modern treatment era
por: Smith, S, et al.
Publicado: (2008)

Disease patterns in juvenile dermatomyositis patients from Mumbai, India
por: Khubchandani, RP, et al.
Publicado: (2011)

Juvenile dermatomyositis in Portuguese children: a case series report
por: Aguiar, Francisca, et al.
Publicado: (2014)

Differences in therapeutic approach to juvenile dermatomyositis between Europe and Latin America
por: Trail, L, et al.
Publicado: (2008)

PReS-FINAL-2008: Juvenile dermatomyositis: a report of 22 cases
por: Souto, A, et al.
Publicado: (2013)

Regulatory B cell Il-10 production is diminished in juvenile dermatomyositis
por: Piper, Christopher, et al.
Publicado: (2014)

PReS-FINAL-2010: Predictive value of whole-body MRI in juvenile dermatomyositis
por: Malattia, C, et al.
Publicado: (2013)

Successful autologous stem cell transplantation (ASCT) in a patient with juvenile dermatomyositis
por: Holzer, U, et al.
Publicado: (2008)

Development and initial validation of a new functional ability tool for juvenile dermatomyositis
por: Varnier, GC, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_gc1tdji9d8ijum0716clhf45fh